Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.

Fu F, Li W, Lu L, Thomson AW, Fung JJ, Qian S. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.

View in: PubMed

collapse authors with profiles